Literature DB >> 25436874

Switching of the triplet excited state of rhodamine/naphthaleneimide dyads: an experimental and theoretical study.

Xiaoneng Cui, Jianzhang Zhao, Zhangrong Lou, Shujing Li, Huijian Wu, Ke-Li Han1.   

Abstract

Rhodamine-bromonaphthaleneimide (RB-NI) and rhodamine-bromonaphthalenediimide (RB-NDI) dyads were prepared for switching of the triplet excited states. Bromo-NI or bromo-NDI parts in the dyads are the spin converters, i.e., the triplet state producing modules, whereas the RB unit is the acid-activatable electron donor/energy acceptor. NI and NDI absorb at 359 and 541 nm, and the T1 state energy levels are 2.25 and 1.64 eV, respectively. RB undertakes the reversible spirolactam (RB-c) ↔ opened amide (RB-o) transformation. RB-c shows no visible light absorption, and the triplet-state energy level is ET1 = 3.36 eV. Conversely RB-o shows strong absorption at 557 nm, and ET1 is 1.73 eV. Thus, the acid-activated fluorescence-resonance-energy-transfer (FRET) competes with the ISC of NI or NDI. No triplet state was observed for the dyads with nanosecond time-resolved transient absorption spectroscopy. Upon addition of acid, strong fluorescence and long-living triplet excited states were observed. Thus, the producing of triplet state is acid-activatable. The triplet state of RB-NI is localized on RB-o part, whereas in RB-NDI the triplet state is delocalized on both the NDI and RB-o units. The ISC of spin converter was not outcompeted by RET. These studies are useful for switching of triplet excited state.

Entities:  

Year:  2014        PMID: 25436874     DOI: 10.1021/jo502554y

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  1 in total

1.  Enhancing Photodynamic Therapy through Resonance Energy Transfer Constructed Near-Infrared Photosensitized Nanoparticles.

Authors:  Ling Huang; Zhanjun Li; Yang Zhao; Jinyi Yang; Yucheng Yang; Aarushi Iris Pendharkar; Yuanwei Zhang; Sharon Kelmar; Liyong Chen; Wenting Wu; Jianzhang Zhao; Gang Han
Journal:  Adv Mater       Date:  2017-06-06       Impact factor: 30.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.